Objectives To evaluate pelvic magnetic resonance imaging (MRI) interobserver agreement for the detection of deep myometrial invasion, cervical stroma invasion and lymph node metastases in endometrial carcinoma patients in relation to surgical staging. Methods Fifty-seven patients with histologically confirmed endometrial carcinoma were prospectively included in a study of preoperative 1.5-T MRI. Four radiologists, blinded to patient data, independently reviewed the images for the presence of deep myometrial invasion, cervical stroma invasion and lymph node metastases. Kappa coefficients for interobserver agreement and diagnostic performances for each observer were calculated using final surgical staging results (FIGO 09) as reference standard.
Introduction
Endometrial carcinoma is the most common pelvic gynaecological malignancy in industrialised countries, and the incidence is increasing [1] . Treatment and prognosis are influenced by surgical International Federation of Gynaecology and Obstetrics (FIGO) stage including depth of myometrial invasion, cervical stroma infiltration, and lymph node, pelvic or distant metastases. Also, histological subtype and tumour grade have a prognostic impact [1] . Depending on tumour stage, the 5-year survival for endometrial carcinoma patients ranges from 20% to 91%, with 80% survival for all stages [2] . Approximately 75% of tumours are confined to the uterine corpus at primary treatment [1, 2] .
The risk of lymph node metastases correlated highly with depth of myometrial infiltration, cervical stroma invasion, and histopathological subtype and grade [2] . Preoperative identification of high-risk patients is beneficial for two main reasons. First, for cervical stromal invasion, radical hysterectomy with removal of the uterus, cervix, parametrium and upper vagina is recommended [3] . Second, removal of metastatic lymph nodes may be beneficial [4] , although this has not been confirmed in randomised trials [5] . Lymphadenectomy is performed routinely to identify high-risk patients who may benefit from adjuvant therapy. An imaging method that reliably identifies high-risk patients with cervical stroma invasion or lymph node metastases preoperatively could enable a tailored surgical approach avoiding unnecessary invasive procedures in low-risk patients.
Magnetic resonance imaging (MRI) has long been the preferred imaging tool in the preoperative staging for treatment planning for endometrial carcinomas and, in particular, in the evaluation of disease spread within the pelvic region [1, 6, 7] . Ideally, MRI should identify deep myometrial invasion (invasion of ≥50% of the myometrial wall), cervical stroma invasion and extent of local or regional tumour spread, including metastasis to lymph nodes [7] [8] [9] . However, the reported accuracy of MRI in the detection of these findings varies considerably, even in the recent literature [10] [11] [12] [13] [14] . This may be due to the different MRI protocols applied as well as interobserver variability in the interpretation of the diagnostic images.
Among the numerous papers published in the last few decades on MRI in endometrial carcinomas [15] , few reports presented data on interobserver agreement, and then only for two observers [16] [17] [18] [19] [20] [21] . The aims of this study were to evaluate the degree of agreement between several radiologists on pelvic MRI findings of deep myometrial invasion, cervical stroma invasion and lymph node metastases in endometrial carcinomas, and to compare these imaging findings with results from surgical staging.
Materials and methods

Patient series and study setting
This study was performed under institutional review boardapproved protocols with informed consent from the patients. From March 2009 through December 2010, a total of 67 consecutive patients with suspected endometrial carcinoma underwent preoperative pelvic MRI. Ten patients were excluded from this study owing to unconfirmed diagnosis (n09) or incomplete MRI (n01; Fig. 1 ) leaving 57 patients with histologically verified endometrial carcinomas for the study. All imaging was performed and all observers in this study worked at the same university hospital which is a European Society for Gynaecologic Oncology (ESGO) accredited gynaecological cancer centre serving a population of ∼1 million inhabitants.
MRI protocol
MRI was performed on a 1.5-T Siemens Avanto running Syngo MR B17 (Erlangen, Germany) using a six-channel body coil. Details regarding the imaging protocol are given in Fig. 1 . Before imaging, 20 mg butylscopolamine bromide (Buscopan, Boehringer Ingelheim, Germany) was given intravenously. Sagittal and axial oblique (perpendicular to the long axis of the uterine body) T2-weighted images of the uterus were obtained (Fig. 1) . Axial oblique T1-weighted gradient-echo images were obtained before and after intravenous contrast medium administration (Dotarem, Guerbet: 0.1 mmol gadolinium per kilogram of body weight, 3 ml/s injection speed) using a 2-min delay. Axial and coronal T2-weighted imaging and axial T1-weighted imaging were acquired up to the renal hila in order to assess lumboaortic lymphadenopathy (Fig. 1) .
MRI reading
All images were de-identified and read independently by four radiologists. Observers 1 (J.R) and 2 (I.J.M) were consultants with >10 years' experience with pelvic MRI, observer 3 (I.S.H) a consultant with >5 years' experience and observer 4 (J.A.H) a resident with ∼2 years' experience. The observers were blinded to clinical data and results from surgical staging. The clinical studies were initially read by one of the five consultants (which included I.J.M.) at the Section for Gynaecological Imaging; for I.J.M the time interval between the initial clinical reading and the de-identified reading was >3 months.
All observers reported imaging findings on a standardised form. For endometrial tumours they recorded primary location, number, size (AP, width and height), minimum distance from tumour to serosa, maximum depth of myometrial invasion and margins (sharp, moderately sharp, or diffuse). Contrast-enhanced T1-weighted images were used to measure tumour size (except sagittal diameter as sagittal contrast-enhanced T1-weighted imaging was not acquired), distance from tumour to serosa and depth of myometrial invasion (assessed at the deepest point in which the tumour extends into the myometrium). Tumour signal intensity relative to normal myometrium (lower, similar, or higher) was recorded on T1-weighted and T2-weighted unenhanced series and contrast-enhanced (CE) T1-weighted series. Cervical stroma invasion (defined as disruption of the low-signal intensity cervical stroma on T2-weighted images), tumour growth in serosa, adnexa, vagina, bladder or rectum, intraperitoneal fluid, enlarged para-aortic or para-iliac lymph nodes (largest short-axis diameter >10 mm), distant metastases and concomitant findings such as uterine adenomyosis and myomas were recorded.
Before analysis, the recorded presence (yes/no) of the three following findings was noted:
1. Deep myometrial invasion (tumour invasion ≥ half of the myometrium) 2. Cervical stroma invasion 3. Enlarged pelvic or para-aortic lymph nodes To establish a combined expert rating, we also computed a new dataset ("expert majority ratings") based on the ratings of the three most experienced observers (observers 1-3). We used the value given by a majority of the three observers for categorical variables and the median value for continuous variables.
Pilot study
To achieve a common understanding of the image reading criteria applied, the observers independently filled in the registration form for five pilot cases not included in the main study. Disagreements were discussed and images reinterpreted to reach consensus.
Reference standard
The reference standard consisted of results from surgical staging according to the revised FIGO staging system (2009) [22] . Surgical specimens were sectioned along the longitudinal plane of the uterus. Depth of myometrial invasion and presence of cervical stroma invasion were estimated grossly and confirmed microscopically according to standard procedures [23] . The evaluation of the surgical specimens was performed in the routine pathology service and without knowledge of preoperative MR findings reported in the study. Lymph node dissection was performed by means of radical resection with anatomical labelling into common, internal and external iliac, internal obturator and lumboaortic node groups by the operating gynaecologist. None of the patients had signs of isolated suprarenal lymphadenopathy based on imaging, and no suprarenal lymph nodes were surgically removed. The fresh resected specimens were scrutinised by the surgeon for abnormal lymph nodes and, subsequently, after fixation by the pathologist. Nodes evaluated as suspicious by the surgeon were sent separately for further investigation and marked for location. The pathologist documented the numbers and size of the metastatic lymph nodes.
Statistical analysis
Overall and pairwise interobserver agreement was measured using exact Fleiss kappa (κ). Agreement beyond chance was interpreted as poor (κ≤0.20), fair (κ00.21-0.40), moderate (κ00.41-0.60), good (κ00.61-0.80) or very good (κ00.81-1.00) [24] . Overall κ for all observers was calculated The lesion is isointense to hypointense relative to surrounding myometrium on a contrast-enhanced T1-weighted image. Three out of four observers judged deep myometrial invasion to be present; the histopathological report concluded that there was only superficial myometrial invasion images show a hyperintense (relative to myometrium) endometrial lesion in the uterine cavity (a) and increased signal of the cervix surrounding the cervical canal (b). Three out of four observers judged cervical stroma invasion to be present; however, the histopathological report did not confirm this with 95% bias corrected confidence interval (CI) based on bootstrapping with 1,000 repetitions.
For MRI findings of deep myometrial invasion, cervical stroma invasion and enlarged lymph nodes, the following analyses were performed:
1. Sensitivity, specificity, accuracy, positive and negative predictive values (with binominal 95% CIs), and number of false positive/negative findings were calculated for each of the four observers and for the expert majority. 2. Differences in sensitivity, specificity and accuracy between observers and the expert majority were collectively analysed with Cochran's exact Q test; if significant, McNemar's test was used for pairwise analysis of the same. 3. Cochran's exact Q test compared prevalence of findings among observers and at surgical staging.
Odds ratios (ORs) for the presence of deep myometrial invasion, cervical stroma invasion and lymph node metastases at surgical staging were calculated using Fisher's exact test for dichotomous variables and univariate logistic regression for continuous and categorical variables. The data were analysed using the Statistical Package for Social Sciences, Version 18.0 (SPSS, Chicago, IL, USA) and Stata 9.0 (College Station, TX, USA). All reported P values were two-sided and considered to indicate statistical significance when less than 0.05.
Results
Patients
Mean patient age in the study sample (n057) was 66 years (range 41-93), and 88% (50/57) were postmenopausal. At surgical staging, applying the FIGO 2009 criteria, 51% (29/ 57) were stage 1A with tumours invading <50% of the myometrium, 23% (13/57) stage 1B with >50% myometrial invasion, 9% (5/57) stage II with cervical stroma invasion and 18% (10/57) stage III with local or regional tumour spread. Histological subtype was endometrioid in 79% (45/57), clear cell in 4% (2/57), serous papillary in 11% (6/57) and carcinosarcoma in 7% (4/57).
The patients were treated with hysterectomy and bilateral salpingo-oophorectomy. Pelvic and/or para-aortic lymph node sampling was performed in 90% (51/57) with an average of 18 nodes sampled (range 2-47). Mean time interval between MRI and hysterectomy was 7.3 days (range 0-36). and mean minimum distance from tumour to serosa was 6 mm (range 0-19). On T2-weighted imaging 98% (56/57) of the tumours were hyperintense relative to the surrounding normal myometrium (Figs. 2 and 3 ). On unenhanced T1-weighted imaging 98% (56/57) of the tumours had lower or similar signal to that of the myometrium, and on contrastenhanced series 95% (54/57) of the tumours had lower signal than the myometrium (Figs. 2 and 4) . Common concomitant findings were uterine adenomyosis (defined as junctional zone thickness ≥12 mm [25] ) found in 12% (7/57) and uterine myomas (with maximum diameter >10 mm) in 44% (25/57). Free intraperitoneal fluid was seen in 18% (10/57), described as moderate amounts in five patients and small amounts in five patients.
Moderate to fair interobserver agreement
In the evaluation of deep myometrial invasion the overall agreement among all observers was fair with a κ value of 0.39 (95% CI 0.26-0.55), and κ values for pairwise agreement ranging from 0.31 to 0.54 among consultants and from 0.16 to 0.54 among the resident and consultants (Table 1) .
For cervical stroma invasion, overall interobserver agreement was moderate, with κ00.50 (95% CI 0.27-0.73), and pairwise agreement ranging from 0.46 to 0.56 among consultants and 0.46 to 0.51 among the resident and consultants ( Table 1) .
The overall agreement was moderate for lymph node metastases with κ00.56 (95% CI 0.09-0.80). Pairwise agreement on lymph node metastases ranged from 0.65 to 0.73 between consultants and 0.36 to 0.63 among the resident and consultants ( Table 1) .
Performance of MRI in loco-regional staging Sensitivity (specificity) values for the four observers ranged from 72 to 92% (44-63%) for deep myometrial invasion, 38 to 63% (82-94%) for cervical stroma invasion and 25 to 38% (88-100%) for lymph node metastases ( Table 2) . Specificity for cervical stroma invasion and specificity and accuracy for detection of lymph node metastases were significantly different among the four observers and the expert majority (Table 2) . Positive (negative) predictive values for deep myometrial invasion, cervical stroma invasion and lymph node metastases were 51-60% (68-89%), 36-63% (90-94%) and 38-100% (88-90%), respectively ( Table 2) . Compared with surgical staging results, all observers tended to overestimate the prevalence of deep myometrial invasion and underestimate the prevalence of lymph node metastases (Fig. 5) .
Odds ratios for surgical staging to confirm positive MRI findings ranged from 2.3 to 11.5 for deep myometrial invasion, from 6.8 to 25.6 for cervical stroma invasion, and from 4.6 to ∞ for lymph node metastases for the different observers (Table 3) . MRI findings were significantly related to the results from surgical staging for most parameters investigated among all observers (Table 3) .
Tumour size on MRI reported by the expert majority was a significant predictive factor for surgical staging findings of deep myometrial invasion (OR 1.12, 1.11 and 1.08 for width, AP and height (mm), respectively; P≤0.001 for all) Fig. 5 Prevalence of deep myometrial invasion, cervical stroma invasion and lymph node metastases reported by the four observers and defined by surgical staging. For deep myometrial invasion and lymph node metastases the prevalence of the reported findings was significantly different for the five groups (Cochran's exact Q test) cervical stroma invasion (OR 1.05, 1.06 and 1.05 for width, AP and height [mm]; P00.03, 0.03 and 0.003, respectively), and lymph node metastases (OR 1.04 for height [mm]; P00.02). Deep myometrial invasion reported by the expert majority on MRI did not predict cervical stroma invasion or presence of lymph node metastases at surgical staging. Nor did the expert majority report free intraperitoneal fluid predicting deep myometrial invasion, cervical stroma invasion or lymph node metastases.
Discussion
Knowledge of inter-rater agreement is crucial for evaluating the usefulness of a diagnostic test; yet many tests are implemented in the clinic despite a lack of such knowledge [24] . Inherent subjectivity in image evaluation represents an important source of variability that affects overall test reproducibility [26] . Thus, concordance measures between observers constitute a key element in establishing the accuracy of an imaging method for the detection and staging of diseases [27] . The present study is to the best of our knowledge the largest and most comprehensive report on interobserver variability for pelvic MRI in endometrial cancers to date. It is also one of the first reports on MRI in endometrial carcinomas in relation to the revised FIGO 2009 staging system.
We identified modest agreement among the four observers on preoperative staging of endometrial carcinomas by MRI, with only fair overall agreement for deep myometrial invasion (κ00.39) and moderate agreement for cervical stroma invasion (κ00.50), and lymph node metastases (κ00.56). Three previous studies on interobserver variation in the preoperative MRI staging of endometrial carcinomas included only two observers [16] [17] [18] . Hori et al. [16] reported good interobserver agreement on T2-weighted imaging for deep myometrial invasion (κ00.66/0.67 at 3.0 T and 1.5 T, respectively), cervical stroma invasion (κ00.77/0.76), and lymph node metastases (κ00.64/0.74). Similarly, Lin et al. [17] found good to excellent agreement on myometrial invasion on 3.0-T T2-weighted imaging (κ00.63), dynamic contrast-enhanced T1-weighted imaging (κ00.84), and fused diffusion weighted imaging (DWI; κ00.79). Another study reported varying interobserver agreement for deep myometrial invasion depending on the imaging sequence, with good to excellent agreement on 1.5-T T2-weighted imaging (κ00.91) and diffusion weighted imaging (κ00.74) and moderate agreement on dynamic contrast-enhanced T1-weighted imaging (κ0 0.45) [18] . These κ values are not directly comparable to those of our study because of different imaging protocols and categorisation of the variables studied [16] [17] [18] . It is, however, reasonable to conclude that interobserver agreement for MRI staging of endometrial carcinomas in the present study is within the lower range of that previously reported [16] [17] [18] .
An explanation for the low interobserver agreement among both experienced and less experienced observers in this study is not obvious. The evaluation of myometrial invasion was primarily based on contrast-enhanced T1-weighted imaging acquired in the equilibrium phase (2-min delay) as opposed to dynamic contrast-enhanced series used in the studies giving data for contrast-enhanced T1-weighted imaging [17, 18] . The equilibrium phase is, however, optimal for assessment of deep myometrial invasion [28, 29] . As the revised FIGO staging system [22] does not discriminate between tumour confined to the endometrium and tumour invading the inner 50% of the myometrium, merged as FIGO stage 1A in the 2009 revision, it has been advocated that early enhanced images, suited to detecting superficial myometrial invasion, are unnecessary [29] . Thus, it is unlikely that the differences in protocols have greatly affected the results of myometrial invasion assessment.
Interestingly, pairwise agreement among all observers was relatively similar (Table 1) irrespective of the observers' previous experience with pelvic MRI. Thus, the duration of non-standardised training in pelvic MR imaging does not seem to have a significant impact on the degree of interobserver variability or staging accuracy for endometrial carcinomas. Whether a more dedicated training programme could potentially reduce the degree of interobserver variability remains to be explored in future studies. Staging the performance of MRI for all four observers and the expert majority was also mostly within the lower range of that reported in the recent literature, but with lower specificity of 44-63% (figures in recent literature: 72-100%) for deep myometrial invasion [10-14, 16, 30-37] . This is explained by the tendency of all observers to overestimate the prevalence of deep myometrial invasion (Fig. 5) . This tendency is also reported by others [18, 38] and can be due to overestimation of tumour invasion into the myometrium combined with underestimation of myometrial thickness on T2-weighted and contrast-enhanced T1-weighted imaging [18] . Over-reading of abnormal findings due to a study setting, could also possibly explain the overestimation of deep myometrial invasion by all the observers. We have analysed the 25 cases in which the clinical reading was also performed by one of the observers (observer 2 for all cases). We found that observer 2 judged deep myometrial invasion to be present slightly more often, 60% (15/25) in the study setting compared with 52% (13/25) in the clinical setting, although this was not statistically significant. Still, overstaging related to a study setting cannot be ruled out because of the small numbers for this subset analysis.
For detection of metastatic lymph nodes our findings of low sensitivity (25-38%) are similar to those of other studies (17-80%) [10-12, 16, 31, 36] , pinpointing the shortcomings of traditional MRI in identifying normal-sized metastatic lymph nodes (Fig. 4) [13, 39] . This study evaluated the diagnostic performance of MRI using standard final surgical staging and lymph node evaluation by a pathologist as reference standard. We did not attempt to perform a detailed comparison of histopathological lymph node findings and imaging findings of the corresponding node. However, the surgeon was preoperatively aware of the location of suspected metastatic nodes reported in the routine evaluations, and thus aimed to remove those for histopathological evaluation. In abdominopelvic malignancies lymph node assessment by imaging is normally based on the size criterion (of ≥10 mm short-axis diameter) [40] , and we used this criterion alone for imaging stratification of lymph nodes into metastatic and non-metastatic nodes. As irregular nodal contour, central necrosis and increased short axis to long axis ratio are features that may suggest a malignant lymph node [40] , these findings were often reported if present, but not systematically evaluated for reproducibility in this study.
This study has some limitations. First, the study is relatively small and was conducted in a single institution. Second, we did not study newer techniques that may affect staging accuracy such as DWI [17, 18, 41, 42] and dynamic contrast-enhanced MRI with acquisitions in the arterial, venous, equilibrium and late phases [12, 28, 36, 43] . Studies with larger patient cohorts and standardised protocols for these techniques in the preoperative staging of endometrial carcinomas are needed, including estimates of interobserver variability and diagnostic performance. Third, we did not assess intraobserver variability, which is expected to be lower than interobserver variability.
This study documents the performance of standard MRI for the preoperative staging of endometrial carcinomas in a population-based clinical setting. The study showed modest interobserver agreement and diagnostic accuracy for standard MRI in the detection of deep myometrial invasion, cervical stroma invasion and lymph node metastases in patients with endometrial carcinomas. This demonstrates that preoperative evaluation with standard MRI alone is suboptimal in identifying those endometrial carcinoma patients who are at a high risk of deep myometrial infiltration, cervical involvement and spread to lymph nodes. Improved imaging methods applied in combination with careful histological and molecular classification of endometrial biopsies [44] [45] [46] , may improve the preoperative stratification into high-risk and low-risk endometrial carcinoma patients in the future. Implementation of future novel diagnostic imaging methods will need to be thoroughly validated by measures of diagnostic performance and interobserver variability before integration into regular clinical practice.
